Pierre Corby
Equity Analyst
Genebra, Suíça
English, French
Pierre is a Healthcare Investment Specialist in UBP’s Advisory Services team in Geneva, which he joined in 2019.
Pierre brings 20 years of experience in both equity markets and medical science. Prior to joining UBP, Pierre worked for 13 years as a sell-side life sciences analyst in Paris for different brokers and notably participated in the IPO of Moderna at the end of 2018. Before moving to finance, Pierre worked as a scientist specialised in molecular biology and virology for the Pasteur Institute in Hong Kong and for a privately-held biotech company in France.
Pierre is a graduate of the Grenoble Ecole de Management in Grenoble, and also holds a degree in Molecular and Cellular Biology from the University Joseph Fourier, both in Grenoble.